Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Politics : Formerly About Advanced Micro Devices -- Ignore unavailable to you. Want to Upgrade?

To: PKRBKR who wrote (1222052)	4/18/2020 6:17:22 PM
From: Land Shark	1 Recommendation Recommended By pocotrader Respond to of 1583680

To: PKRBKR who wrote (1222052)	4/18/2020 6:23:28 PM
From: Wharf Rat	1 Recommendation Recommended By pocotrader Read Replies (1) \| Respond to of 1583680

Now that is one of the truly great whines of 2020, but, of course it's esate bottled, not a Trump Whinery product. COVID-19 testing on Abbott lab machines running far short of need APRIL 9, 2020 BY NANCY CROTTI U.S. laboratories are not running enough COVID-19 diagnostic tests using Abbott (NYSE: ABT) m2000 RealTime machines, according to Dr. Deborah Birx, White House coronavirus response coordinator. During last night’s White House briefing, Birx said that 80% of the Abbott machines in 120 laboratories across the country are not running, despite the availability of 1 million tests. Abbott said in March, when it received FDA emergency use authorization for a coronavirus test, that each of the more than 175 m2000 systems in U.S. labs can run up to 470 tests in 24 hours. A the time, the company promised to deploy additional m2000 systems as needed. “I made a big push and Abbott was extraordinary about getting those out to the labs,” Birx said last night. “I mean, this is not sitting in a warehouse. These are physically in these laboratories, sitting there right now.” massdevice.com